The blog
Clinical trial results, TGA regulatory progress and research updates on retatrutide and the wider peptide space — explained for Australians.
13 September 2026 · epithalon · peptides · longevity · regulation
Epithalon research has no published human pharmacokinetic study. What that means for dosing claims, the 2025 independent lab data and epithalon in Australia.
Read more →11 September 2026 · epithalon · epitalon · peptides · longevity · tga
Is epithalon legal in Australia, and does the famous 28% mortality figure even apply? We separate synthetic epitalon from Epithalamin and check the evidence.
Read more →28 August 2026 · epithalon · epitalon · telomeres · peptides · australia
Is epithalon legal in Australia, and what does epitalon research show? A 2025 human-cell study found telomere growth - but maybe not via telomerase.
Read more →27 August 2026 · epithalon · peptides · longevity · research
Epithalon (epitalon) is sold as a longevity peptide that lengthens telomeres. We look at what the research actually shows and its Australian status.
Read more →Stay informed
Retatrutide is not yet available to the public. But when it is, you will want to be first to know. Sign up to receive:
Get the free guide + updates
Enter your details once on our free access guide page — instant download, plus we'll email you the moment there's real news.